A phase III evaluation of a somatostatin analogue (octreotide) in the treatment of patients with asymptomatic advanced colon carcinoma. [electronic resource]
Producer: 19960722Description: 1956-7 p. digitalISSN:- 0008-543X
- Antineoplastic Agents, Hormonal -- administration & dosage
- Carcinoma -- drug therapy
- Clinical Trials, Phase III as Topic
- Colonic Neoplasms -- drug therapy
- Hormone Antagonists -- administration & dosage
- Humans
- Neoplasm Staging
- Octreotide -- administration & dosage
- Rectal Neoplasms -- drug therapy
- Somatostatin -- administration & dosage
- Survival Rate
No physical items for this record
Publication Type: Comment; Letter
There are no comments on this title.
Log in to your account to post a comment.